- Home
- CLDX vs CLOV Comparison
CLDX vs CLOV Comparison
Compare CLDX & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CLOV
- Stock Information
- Founded
- CLDX N/A
- CLOV 2014
- Country
- CLDX United States
- CLOV United States
- Employees
- CLDX N/A
- CLOV N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CLOV Medical Specialities
- Sector
- CLDX Health Care
- CLOV Health Care
- Exchange
- CLDX Nasdaq
- CLOV Nasdaq
- Market Cap
- CLDX 1.6B
- CLOV 1.4B
- IPO Year
- CLDX 2008
- CLOV N/A
- Fundamental
- Price
- CLDX $26.22
- CLOV $2.72
- Analyst Decision
- CLDX Strong Buy
- CLOV Strong Buy
- Analyst Count
- CLDX 8
- CLOV 3
- Target Price
- CLDX $46.13
- CLOV $4.37
- AVG Volume (30 Days)
- CLDX 1.1M
- CLOV 9.3M
- Earning Date
- CLDX 11-05-2025
- CLOV 11-04-2025
- Dividend Yield
- CLDX N/A
- CLOV N/A
- EPS Growth
- CLDX N/A
- CLOV N/A
- EPS
- CLDX N/A
- CLOV N/A
- Revenue
- CLDX $5,790,000.00
- CLOV $1,607,900,000.00
- Revenue This Year
- CLDX N/A
- CLOV $39.93
- Revenue Next Year
- CLDX N/A
- CLOV $28.94
- P/E Ratio
- CLDX N/A
- CLOV N/A
- Revenue Growth
- CLDX N/A
- CLOV 22.12
- 52 Week Low
- CLDX $14.40
- CLOV $2.12
- 52 Week High
- CLDX $31.66
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- CLDX 60.30
- CLOV 44.10
- Support Level
- CLDX $24.49
- CLOV $2.51
- Resistance Level
- CLDX $26.90
- CLOV $3.26
- Average True Range (ATR)
- CLDX 1.00
- CLOV 0.17
- MACD
- CLDX 0.07
- CLOV -0.07
- Stochastic Oscillator
- CLDX 79.27
- CLOV 26.19
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.